Search

Novavax Inc

Suletud

SektorTervishoid

10.4 3.07

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.09

Max

10.66

Põhinäitajad

By Trading Economics

Sissetulek

-44M

-53M

Müük

-83M

57M

P/E

Sektori keskmine

3.112

56.432

Aktsiakasum

-0.32

Kasumimarginaal

-94.16

Töötajad

749

EBITDA

-39M

-40M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+8.87% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. nov 2026

Turustatistika

By TradingEconomics

Turukapital

363M

1.6B

Eelmine avamishind

7.33

Eelmine sulgemishind

10.4

Uudiste sentiment

By Acuity

62%

38%

271 / 339 Pingereas Healthcare

Novavax Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. sept 2026, 19:55 UTC

Novavax Inc is trading higher, maintaining a strong performance and remaining significantly above its 20-day moving average despite notable volatility today.

18. sept 2026, 20:06 UTC

Novavax Inc shares are higher in Friday's trading session, recovering from mid-morning lows and maintaining a position above the 20-day moving average.

17. sept 2026, 20:02 UTC

Novavax Inc is advancing, continuing sharp gains since Wednesday, despite earlier pulling back from a session high amid broader market weakness.

16. sept 2026, 23:21 UTC

Novavax Inc's stock is modestly lower in after-market trading, following earlier volatility and currently trading below its 20-day moving average.

15. sept 2026, 22:51 UTC

Novavax Inc. shares are lower in after-market hours, reflecting broader economic concerns following a decline in the NY Empire State Manufacturing Index.

14. sept 2026, 23:36 UTC

Novavax shares are trading lower in after-market hours, following a broader decline in U.S. stocks amid rising crude oil prices and supply concerns.

11. sept 2026, 20:08 UTC

Novavax Inc. shares are higher during Friday's session, having reached a session high earlier before pulling back. No specific news was identified.

10. sept 2026, 23:01 UTC

Novavax Inc. shares are lower in after-market hours, continuing recent downward trends. The stock reached its lowest point shortly after the market reopened.

9. sept 2026, 19:46 UTC

Social Media

Novavax Inc shares are lower amid ongoing volatility following first-quarter results. The stock has faced pressure, dipping below $11.50 earlier in the session.

8. sept 2026, 19:26 UTC

Novavax Inc. shares are trading roughly flat, reflecting minimal change since Friday's close amid broader market trends. The asset remains above its 20-day moving average.

4. sept 2026, 23:15 UTC

Novavax Inc. shares are lower in after-market hours, reflecting a slight decline since Friday's close amid rising Treasury yields and interest rate expectations.

3. sept 2026, 23:05 UTC

Novavax Inc. shares are lower in after-market trading, despite remaining above their 20-day moving average and showing significant gains from a month ago.

2. sept 2026, 23:06 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

1. sept 2026, 23:31 UTC

Novavax Inc. shares are lower in after-market trading, showing volatility since Tuesday's close, though the stock remains well above its 20-day moving average.

31. aug 2026, 23:01 UTC

Novavax Inc shares are higher in after-market trading, continuing a strong three-session performance. No specific news was identified to explain the movement.

28. aug 2026, 23:01 UTC

Novavax Inc shares declined in after-market trading, amid rising market expectations for an interest rate hike and upward pressure on Treasury yields.

27. aug 2026, 23:01 UTC

Novavax Inc. shares are higher in after-market trading, rebounding from earlier volatility and remaining above the 20-day moving average.

26. aug 2026, 20:08 UTC

Novavax Inc shares are lower as the biotechnology sector declines. The stock rebounded earlier in the session but has since pulled back.

25. aug 2026, 20:07 UTC

Novavax Inc shares are higher Tuesday, supported by lower Treasury yields. The stock pulled back from an intraday high but remains up since Monday.

24. aug 2026, 20:04 UTC

Novavax shares are lower today, reflecting broader market trends, with no specific company news identified. The stock remains above its 20-day moving average.

21. aug 2026, 23:31 UTC

Novavax Inc. shares declined in after-market trading, moving within a narrow range since Friday's close. The stock remains above its 20-day moving average.

20. aug 2026, 19:02 UTC

Macro Event

Novavax shares are trading lower amid negative jobless claims data, reflecting broader market fluctuations and a significant decline since Wednesday's close.

19. aug 2026, 23:51 UTC

Novavax Inc. shares are lower in after-market hours amid broader declines in biotechnology stocks, despite an earlier session peak above Wednesday's close.

17. aug 2026, 19:36 UTC

Novavax Inc is trading higher, reaching a session peak earlier today. The stock remains at the upper end of its one-month trading range.

14. aug 2026, 23:26 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of the one-month range.

13. aug 2026, 19:16 UTC

Novavax Inc. shares are higher today, maintaining strength above the 20-day moving average despite rising initial jobless claims reported by the Labor Department.

12. aug 2026, 23:31 UTC

Novavax Inc. shares are lower in after-market trading, reflecting a weaker trend despite earlier gains. The stock remains above its 20-day moving average.

11. aug 2026, 23:51 UTC

Novavax Inc. shares are higher in after-market trading, maintaining a position above the 20-day moving average within its one-month trading range.

10. aug 2026, 23:46 UTC

Novavax Inc. shares are lower in after-market trading, showing some volatility since Monday's close and remaining within the middle of their one-month trading range.

7. aug 2026, 19:36 UTC

News

Novavax Inc shares are higher today, supported by $57 million in second-quarter revenue and ongoing discussions with Sanofi on a COVID-19/influenza vaccine.

Võrdlus sarnastega

Hinnamuutus

Novavax Inc Prognoos

Hinnasiht

By TipRanks

8.87% tõus

12 kuu keskmine prognoos

Keskmine 11.333 USD  8.87%

Kõrge 18 USD

Madal 7 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Novavax Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

3 ratings

1

Osta

1

Hoia

1

Müü

Sentiment

By Acuity

271 / 339 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.